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Background: Limb immobilization causes a rapid loss of muscle mass and strength that requires appropriate
rehabilitation to ensure restoration of normal function. Whereas the knowledge of muscle mass signaling with
immobilization has increased in recent years, the molecular regulation in the rehabilitation of immobilization-
induced muscle atrophy is only sparsely studied. To investigate the phosphorylation and expression of candidate
key molecular muscle mass regulators after immobilization and subsequent rehabilitation we performed two
separate studies.
Methods: We immobilized the lower limb for 2 weeks followed by the in-house hospital standard physiotherapy
rehabilitation (Study 1). Secondly, we conducted an intervention study using the same 2 weeks immobilization
protocol during which protein/carbohydrate supplementation was given. This was followed by 6 weeks of
rehabilitation in the form of resistance training and continued protein/carbohydrate supplementation (Study 2). We
obtained muscle biopsies from the medial gastrocnemius prior to immobilization (PRE), post-immobilization (IMMO)
and post-rehabilitation (REHAB) and measured protein expression and phosphorylation of Akt, mTOR, S6k, 4E-BP1,
GSK3β, ubiquitin and MURF1 and mRNA expression of Atrogin-1, MURF1, FOXO1, 3 and 4 as well as appropriate
housekeeping genes.
Results: In both studies, no changes in protein expression or phosphorylation for any measured protein were
observed. In Study 1, FOXO3 and FOXO4 mRNA expression decreased after IMMO and REHAB compared to PRE,
whereas other mRNAs remained unchanged. Interestingly, we found significant changes in expression of the
putative housekeeping genes GAPDH, HADHA and S26 with immobilization in both studies.
Conclusions: In neither study, the changes in muscle mass associated with immobilization and rehabilitation were
accompanied by expected changes in expression of atrophy-related genes or phosphorylation along the Akt axis.
Unexpectedly, we observed significant changes in several of the so-called housekeeping genes GAPDH, HADHA and
S26 with immobilization in both studies, thereby questioning the usefulness of these genes for normalization of
RNA data purposes in muscle immobilization studies.
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Human skeletal muscle loss is a common consequence
of physical inactivity, immobilization, aging and disease
[1-5]. Two to three weeks of immobilization causes a
loss of muscle mass of 5–10%, accompanied by a de-
crease in strength of 10–20% [6-8], and, accordingly,
individuals with injuries that require immobilization of a
limb experience a rapid loss of muscle mass and
strength. The recovery from such an injury can be com-
plicated by the lag time for strength recovery and is es-
pecially true for vulnerable population groups including
older and/or frail adults [9].
Effective and quick rehabilitation of muscle mass and
especially strength is of key importance to the immobi-
lized individual. Resistance exercise training and ad-
equate nutrition elicit increased muscle mass and
strength [10], and combining resistance exercise and es-
sential amino acids plus carbohydrates enhance muscle
protein synthesis to a greater degree than either stimulus
alone [10,11]. In addition, discrepant results on the effect
of amino acid supplementation on muscle loss with
immobilization have been reported [12,13].
Despite the importance of appropriate recovery, the re-
habilitation of muscle mass and function following
immobilization is understudied [14,15] and whereas the
knowledge of muscle mass signaling with immobilization
has increased in recent years, there is a paucity of studies
on the molecular regulation of muscle mass in the re-
habilitation of immobilization-induced muscle atrophy [7].
Muscle mass is regulated by the relative rates of pro-
tein synthesis and protein breakdown, and the molecular
regulation of this includes the key Akt, mammalian tar-
get of rapamycin (mTOR), glycogen synthase kinase 3β
(GSK3β) and Forkhead box O (FOXO) signaling path-
ways [16,17]. Akt is activated by insulin and insulin-like
growth factor 1 (IGF-1), and the forced transgenic or
pharmacologic induction of Akt in vivo or in vitro is suf-
ficient to cause dramatic muscle hypertrophy and inhibit
atrophy [18-22]. Akt affects protein synthesis by allowing
assembly of a translation initiation complex through
GSK3β and mTOR, of which mTOR activates and inhi-
bits its downstream targets ribosomal protein S6 kinase
(S6k) and eukaryotic translation initiation factor 4E bind-
ing protein 1 (4E-BP1), respectively. Akt also inhibits
FOXO transcription factors, which consist of FOXO1, 3
and 4 in skeletal muscle. The activation of FOXO3
induces muscle loss as well as protein degradation and sti-
mulates the transcription of the ubiquitin ligases Atrogin-1
and Muscle Ring Finger protein 1 (MURF1), which to-
gether with FOXO1 belong to a set of muscle atrophy-
related genes (“atrogenes”) that are upregulated in several
types of murine muscle atrophy [18,23-25].
Accordingly, to investigate the phosphorylation and ex-
pression of candidate key molecular muscle massregulators after immobilization and subsequent rehabilita-
tion, we performed two separate studies. First, we immobi-
lized the lower limb for 2 weeks followed by the in-house
hospital standard physiotherapy rehabilitation for another
2 weeks. The aim of the first study was to characterize the
effects of the immobilization protocol and standard re-
habilitation on muscle signaling and mRNA expression
(Study 1). Secondly, we conducted an intervention study
using the same 2 weeks immobilization protocol during
which protein/carbohydrate supplementation was given.
This was followed by 6 weeks of rehabilitation in the form
of resistance training and continued protein/carbohydrate
supplementation. The aim of the second study was to ex-
plore the effects of a resistance training and nutrient sup-
plementation based intervention on muscle signaling and
mRNA expression during the recovery from immobilization
(Study 2). 6 weeks rehabilitation training was selected in
order to aim for full recovery of strength and mass. A
protocol of 6 weeks of resistance training rehabilitation after
2 weeks of immobilization has been used previously by
others investigating the response of the thigh muscles [7].
For Study 1, we hypothesized that the 2 weeks
immobilization would decrease Akt and mTOR signaling
along with increased FOXO3, Atrogin-1 and MURF1
mRNA expression, reflecting the loss of muscle mass
reported previously for this study [26]. Further, we
hypothesized that the standard rehabilitation would be
insufficient to recover signaling and mRNA expression
relative to post-immobilization. For Study 2, we hypothe-
sized (similar to Study 1) decreased Akt and mTOR sig-
naling along with elevated FOXO3, Atrogin-1 and
MURF1 transcripts after immobilization. Regarding the
subsequent resistance training and protein/carbohydrate
supplement based rehabilitation, we hypothesized a full
recovery of mass and strength, reflected by a reversal or
normalization to basal levels of signaling and mRNA ex-
pression. Of note, as Study 1 and Study 2 are separate




8 young men (Table 1) were recruited following online
advertising and included in Study 1. As this study also
investigated tendon collagen synthesis [26], which is
affected by the hormones of contraceptive pills, estradiol
and progesterone [27], females were excluded. Eligibility
criteria were: Male, 18–30 years of age, no chronic dis-
ease, no use of medication, no injuries in the lower body
and no obesity (BMI> 30). Incidentally, all were Cauca-
sians and most of the subjects were recreationally active
students. All subjects gave, after receiving oral and writ-
ten information, written, informed consent to participate
in the study, in adherence to the declaration of Helsinki.
Table 1 Subject characteristics
Attribute Unit Study 1 Study 2
Height (cm) 184 ± 9 184 ± 7
Weight (kg) 85 ± 12 84 ± 12
Age (years) 23 ± 3 24 ± 3
BMI (kg*m-2) 26 ± 3 25 ± 3
Bodyfat (%) NR 19.9 ± 5.5
Self-reported PAL-factor NR 1.78 ± 0.36
Avg. fat intake (g) NR 69.3 ± 23.8
Avg. carbohydrate intake (g) NR 267.5 ± 58.3
Avg. protein intake (g) NR 90.3 ± 30.3
Avg. protein intake (g/kg) NR 1.2 ± 0.3
Subject characteristics for Study 1 and Study 2. NR is short for “not recorded”.
Data are presented as means ± SD.
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[(KF) 11 2006–1743].
Study 1: Design
The subjects were assigned to 2 weeks of immobilizing
casting of the lower leg in the non-dominant side, fol-
lowed by 2 weeks of standard physiotherapy rehabilita-
tion (Figure 1), with the other leg serving as a control.
Muscle biopsies were sampled 1 week prior toFigure 1 Study setup. Study setup and flowchart for Study 1 and 2. Musc
measurements were bilateral from casted and control legs.immobilization (PRE), after the 2-week immobilization
period (IMMO) and following 2 weeks of rehabilitation
(REHAB (2 W)), and from these biopsies mRNA and
protein were isolated for use in RT-qPCR and Western
blots. Strength and muscle cross-sectional area (CSA)
data from this study have been published previously [26].
Study 1: Standard rehabilitation protocol
Subjects in Study 1 performed 2 weeks rehabilitation as
per standard in-house hospital physiotherapy recommen-
dations at the orthopedic department at Copenhagen
University Hospital at Bispebjerg. This protocol was
selected in order to characterize the effects of a standard
rehabilitation course. This protocol is aimed at mobiliz-
ing the joint and reactivating neuromuscular and
kinesthetic skills, more so than improving tissue protein
turnover or muscle metabolism and strength.
Each of the following exercises were to be performed
for approximately 60 s daily: 1) slow flexing/stretching of
toes, 2) while seated, lifting a cloth off the floor, gripping
it with the toes, 3) while seated, slowly sliding the foot
back and forth on a cloth, keeping the heel in contact
with the floor, 4) while standing, lifting the toes, 5) while
standing, doing calf raises, 6) while standing, doing short
lunges, performed until the knee passes the toes, 7)
straight knee stretching (targeting the gastrocnemiusle biopsies were only taken from the casted leg. All other
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muscle). The subjects did not maintain exercise logs.
Study 2: Subjects
In Study 2, another 8 young men (Table 1) were included
from similar advertising and recruiting procedures and
on the basis of similar eligibility criteria. All subjects
gave, after receiving oral and written information, written
consent to participate in the study, in adherence to the
declaration of Helsinki. The study was approved by the
local Human Subject Ethics Committee of Copenhagen
and Frederiksberg [(H KF) 319605].
Study 2: Design
In Study 2, subjects were assigned to an immobilization
procedure identical to that used in Study 1, but to another
rehabilitation protocol comprised of resistance training for
6 weeks. Moreover, the subjects received protein/carbohy-
drate supplementation throughout both the immobilization
and the rehabilitation period (Figure 1).
Muscle biopsies were sampled 1 week prior to
immobilization (PRE), following immobilization (IMMO)
and following 6 weeks of rehabilitation (REHAB (6 W))
and muscle size was measured by MRI at the same time
points. Muscle strength was measured after 2 (REHAB
2 W) and 6 (REHAB (6 W) weeks of rehabilitation and
muscle CSA was measured at the REHAB (6 W) time
point as well. Muscle strength and size data from the PRE
and IMMO time points in this study have been reported
elsewhere [28]. Muscle strength and size were measured as
described previously [28,29] Briefly, strength was maximal
voluntary (isometric) plantarflexion strength with extended
knee exerted against a plate connected to a strain gauge,
while muscle CSA was measured from MR slice scans
10 cm distal to the caput fibula.
Study 2: Rehabilitation exercise protocol
Subjects in Study 2 performed resistance training direc-
ted at increasing strength, muscular endurance and in-
crease connective tissue protein turnover [26] three
times a week. During weeks 1 and 2, subjects performed
2x15 (set x repetitions) single-legged standing toe raises
at bodyweight with full range of motion and 2x15 toe
presses in a seated leg press machine at 15–20 repetition
maximum (RM). During weeks 3 and 4, subjects per-
formed 3x15 single-legged standing toe raises with add-
itional 10% bodyweight added and 3x15 eccentric toe
presses with progressive weight increases (using both
legs in the concentric phase, but only one in the eccen-
tric). During weeks 5 and 6, subjects performed the same
number of set and repetitions, but with 20% bodyweight
added for toe raises. The training was done supervised
in-house at the hospital gym and subjects maintained ex-
ercise logs that were validated by instructors.Study 2: Protein and carbohydrate supplement protocol
Prior to immobilization and during the rehabilitation
period, subjects in Study 2 maintained food logs for
3 days, which were used to calculate average habitual nu-
trient and protein intakes (Table 1).
During the full study (immobilization and rehabilitation),
all subjects were instructed to ingest a protein and carbo-
hydrate supplement (20 g of protein and 25 g of dextrose)
twice daily and always after exercise. Ingestion of the pro-
tein and carbohydrate supplement was monitored only fol-
lowing workouts. The supplement represented a daily
addition to protein and energy consumption of 44 and
16%, respectively or an increase in protein consumption of
0.5 ± 0.1 g*kg−1*day−1. Protein/carbohydrate supplementa-
tion began on the first day of immobilization and was con-
tinued until the last testing session.
The subjects were administered milk protein: 4 were
given whey protein (Lacprodan Whey protein isolate,
Arla), and 4 were given alpha-lactalbumin (Lacprodan
Alpha-10, Arla; a whey subfraction protein), but as statis-
tical endpoint analysis yielded no difference between
these protein supplements at any time, they were pooled
for all purposes. These two protein supplements have
fairly similar amino acid compositions, e.g. both contain
21% branched-chain amino acids.
Immobilization
In both studies, the ankle joint and lower part of the non-
dominant leg was immobilized in a 90° angle using a cast
from below the knee to the toes, leaving the Achilles ten-
don in a neutral position. The subjects were supplied with
crutches and instructed to avoid any load-bearing on the
immobilized leg. After the 2 weeks of immobilization, the
cast was checked for evidence of weight-bearing (any vis-
ible damage or marks after load bearing would exclude the
subject), removed, and the subjects were tested and
sampled again. Following cast removal, subjects were
transported in a wheelchair to the MRI facility and back to
the laboratory in order to avoid supporting on the immo-
bilized leg prior to muscle biopsy sampling.
Muscle biopsy sampling
In both studies, biopsies were sampled from the medial
gastrocnemius muscle, using the percutaneous Bergström
needle technique [30]. Biopsies were obtained only from
the casted leg and not the control leg. Before taking the bi-
opsies, ultrasound imaging was used to identify areas of
the muscle with large vessels that should be avoided dur-
ing the sampling, to prevent unnecessary intramuscular
hematomas. Individual biopsy sites were moved 2–3 cm
between repeated samplings. In both studies, subjects were
sampled at the PRE, IMMO and REHAB time point, with
REHAB being after 2 weeks of rehabilitation in Study 1
and after 6 weeks in Study 2.
Table 2 Antibody and primer specifications
Primary Antibodies
Epitope Manufacturer Catalog no. Dilution
Akt Cell Signaling 2920 1:2,000
p-Akt (T308) Cell Signaling 2965 1:2,000
p-Akt (S473) Cell Signaling 4060 1:2,000
mTOR Cell Signaling 2983 1:2,000
p-mTOR (S2448) Cell Signaling 2971 1:2,000
p-mTOR (S2481) Cell Signaling 2974 1:2,000
S6K Cell Signaling 9202 1:2,000
p-S6K (T389) Cell Signaling 9206 1:2,000
GSK3β Abcam Ab31826 1:2,000
P-GSK3β (S9) Cell Signaling 9336 1:2,000
4E-BP1 Santa Cruz Sc-81149 1:200
p-4E-BP1 (T37/46) Cell Signaling 2855 1:2,000




Manufacturer Catalog no. Dilution
Mouse Ig Alexa 680 Invitrogen A21057 1:10,000
Goat Ig Alexa 680 Invitrogen A21084 1:10,000























Specification of antibodies used for Western blots and primers used for qPCR.
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In both studies, approximately 10 mg of muscle tissue was
used for RNA isolation. RNA was isolated using phenol ex-
traction [31], using the Trizol kit (Tri-Reagent, Molecular
Research). The isolation was performed essentially as pro-
posed, but with two subsequent ethanol precipitation
steps, rather than one. The tissue homogenization step
was performed using a bead beater (Fastprep-24, MP Bio-
medicals) shaking specimens in 1 ml Trizol in a 2 ml Bios-
pec tube with 5 stainless steel beads (2.3 mm) and 5
silicon carbide grains for 15 s at speed 4.0 twice. Between
shakings samples rested in an ice-water bath. RNA integ-
rity was measured by electrophoresis, running 200 nano-
grams of RNA on a denaturing agarose gel and visualized
with SYBR Green II staining.
Realtime RT-qPCR
In both studies, the mRNA expression of FOXO4 and the
atrophy-related genes FOXO1, FOXO3, Atrogin-1 and
MURF1 [23,25] was analyzed by real-time RT-qPCR. Total
RNA (500 ng) was converted into cDNA in 20 μl using the
OmniScript reverse transcriptase kit (Qiagen, CA, USA)
and poly-dT according to the manufacturer’s protocol. For
each target, 0.25 μl cDNA was amplified in a 25 μl SYBR
Green PCR reaction containing 1X Quantitect SYBR
Green Master Mix (Qiagen) and 100 nM of each primer
(Table 2). The amplification was monitored real-time using
the MX3000P real-time PCR machine (Stratagene). The
threshold cycle (Ct) values were related to a standard
curve made with the cloned PCR products and specificity
ensured by melting curve analyses.
In the initial PCR assay we measured Glyceraldehyde 3-
phosphate dehydogenase (GAPDH) and Ribosomal protein,
large, P0 (RPLP0) expression for normalization purposes,
but as their expression changed in relation to each other,
we proceeded to measure more putative housekeeping
genes (26S, β2-microglobulin, Cyclophillin A and HADHA)
in another assay. Therefore, we measured expression of six
putatively stably expressed “housekeeping” genes
GAPDH, RPLP0, β2-microglobulin (β2MG), Cyclophil-
lin A, hydroxyacyl-coenzyme A dehydrogenase alpha
subunit (HADHA) and ribosomal protein S26 (S26) and
did indeed find significant variation within these sup-
posedly stably expressed genes (See Results section).
Thus, we proceeded to use the “GeNorm” algorithm
(VBA applet for Excel) [32] to identify the housekeeping
genes most stably expressed. The GeNorm housekeeping
gene analysis revealed the most variable genes to be
GAPDH, S26 and HADHA in descending order of vari-
ability. Including β2MG, RPLP0 and Cyclophillin A in the
geometric mean used for normalization yielded a variabil-
ity score of 0.151, complying with the “stability threshold”
score of 0.150 recommended in Vandesompele et al. [32].
We proceeded to generate geometric means of the
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normalization. Statistics were done on normalized and
log-transformed numbers. Finally, we back-transformed
means and SEM’s for reporting and graphical visualization.
Protein isolation
Approximately 10 mg of muscle tissue was homogenized
as described for RNA isolation, but performed in 200 μl
homogenization buffer (50 mM Tris–HCl, 1 mM EDTA,
1 mM EGTA, 10 mM β-glycerophosphate. 50 mM NaF,
0.5 mM sodium orthovanadate, 0.1% 2-mercaptoethanol,
0.1% Triton-X and protease inhibitor (Complete, Roche),
adjusted to pH 7.5). Following bead beating, samples were
briefly spun down and aliquots of the resulting super-
natant were used for protein concentration determination,
using the EZQ protein quantitation kit (Molecular Probes)
and CCD camera (Kodak Image Station 3000MMpro).
Prior to loading, aliquots of the samples were diluted to a
final concentration of 1 ug/ul, using 4X Laemmli buffer, to
a final concentration of 1X Laemmli.
Western blots
In both studies, we measured total protein and phos-
phorylation for Akt (T308 and S473), mTOR (S2448 and
S2481), S6k (T389), 4EBP1 (T37/46) and GSK3β (S9) as
well as protein expression of ubiquitin and MURF1
(Table 2). Western blotting was performed essentially as
previously described [33]. For electrophoresis, 20 μg
protein per well was loaded on Criterion 4–12% gradient
gels (Bio-Rad) and run at 200 V for 1 h. The gels were
cut into pieces corresponding to target sizes. Gel slabs
containing proteins larger than 110 kDa were blotted in
absence of methanol, while the remaining gel pieces
were blotted in the presence of methanol. Gels were
blotted (Trans-blot cell, Bio-Rad, 400 mA, 2 h) to poly-
vinylidene difluoride membranes (Amersham Hybond
LFP, GE Healthcare) in transfer buffer (50 mM Tris-
base, 383 mM glycine, 20% v/v methanol), washed
briefly in distilled water and blocked for 30 min in 10%
Odyssey Blocking buffer in phosphate-buffered saline
(PBS). Following blocking, membranes were washed in
Tris-buffered saline with Tween-20 (TBST) (50 mM pH
7.4 Tris, 150 mM NaCl, 0.1% Tween-20, pH 7.4) and
incubated with primary antibodies (Table 2) overnight.
Following primary antibody incubation, membranes
were washed in TBST and incubated with appropriate
secondary antibodies conjugated to Dylight 800 or Alexa
680 fluorophores (Table 2). For visualization, blots were
scanned using an Odyssey scanner (LiCor) at 84 μm
resolution and standard settings and quantified using
ImageJ (National Institutes of Health, USA). Where ap-
propriate, total and phospho-antibodies were incubated
simultaneously on the same membrane, each in its own
wavelength channel. Prior to statistical analysis, resultswere normalized to individual PRE values and log-
transformed. Finally, we back-transformed means and
SEM’s for reporting and graphical visualization.
Statistics
No statistical comparisons were made between Study 1
and 2, as we consider them separate studies. Statistical
analysis was, however, performed in an identical manner
between the two studies.
For Study 2 only, muscle size (CSA) and strength
(MVC) PRE-normalized data were subjected to repeated
measures one-way ANOVA (and post hoc testing) indi-
vidually for each leg.
Western blot and RT-qPCR data were normalized
as described in their respective paragraphs and log-
transformed prior to being subjected to repeated
measures one-way ANOVA (and post hoc testing).
The log-transformation was used to ensure that the
data approached normal distribution as closely as
possible.
In figures, all data are presented as means±SEM (for RT-
qPCR and Western blot data back-transformed means ±
SEM). In Table 1, data are presented as means ± SD. CSA,
MVC and mRNA analyses were done using Sigmastat
3.5.0.54 (Systat Software, 2006) with Student-Newman-
Keuls correction for multiple testing, whereas protein data
were analyzed using SAS 9.1.3 (SAS Institute 2008). For all




As for mRNA (Figure 2A), we observed significant time
effects for FOXO3 (p=0.004), FOXO4 (p=0.013), GAPDH
(p=0.005), HADHA (p=0.010) and S26 (p=0.037) tran-
scripts. For FOXO3 and FOXO4 this was manifested in the
form of a downregulation at the IMMO time point (−40%
for FOXO3 (p=0.006) and −58% for FOXO4 (p=0.026))
that persisted until the REHAB (2 W) time point (−19% for
FOXO3 (p=0.006) and −35% for FOXO4 (p=0.009)).
GAPDH and HADHA were also downregulated at the
IMMO time point (−53% for GAPDH (p=0.004) and −40%
for HADHA (p=0.008)), but returned almost back to base-
line expression at the REHAB time point. Despite manifest-
ing a time effect, S26 was not significantly downregulated at
either time point (Figure 2A).
Protein expression and phosphorylation
Despite the obvious changes in muscle mass [26], we
observed no significant modulation of total or phospho-
protein levels of Akt, GSK3β, 4EBP1, ubiquitin or
MURF1 in Study 1 (Figure 2B). Total and phosphory-
lated levels of mTOR and S6k were below the detection
threshold.
ab
Figure 2 Data for Study 1. A: mRNA expression measured by RT-qPCR. mRNA data are normalized to geometric means of Cyclophillin A, β2-
microglobulin and RPLP0 and are relative to individual PRE values. Target genes are presented in the left side panel, whereas putative
housekeeping genes are presented in the right side panel. Data are presented as back-transformed mean ± SEM. Light gray columns represent
IMMO and dark gray REHAB. B: Total protein and protein phosphorylation measured by Western blot, relative to individual PRE values. Data are
presented as back-transformed mean ± SEM. Total Akt is represented twice as it was measured along with each phospho-Akt. Light gray columns
represent IMMO and dark gray REHAB. * denotes a difference from PRE with 0.05> p≥ 0.01. ** denotes a difference from PRE with
0.01> p≥ 0.001. Underscored asterisks denote main (time) effects.
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Muscle strength and size
In Study 2, we report additional muscle strength and
size data for the REHAB time points. For strength, no
significant time effects were detected in either leg.
Following 2 and 6 weeks of rehabilitation, strength
was elevated to levels slightly higher than those
recorded before immobilization, but these differences
did not reach significance. For muscle size, no differ-
ences were observed between the REHAB (6 W) time
point and PRE.
mRNA expression
For mRNA (Figure 3A), we observed time effects for
FOXO1 (p = 0.030), Atrogin-1 (p = 0.046), GAPDH
(p = 0.001), HADHA (p = 0.035) and S26 (p = 0.001).
Notably, for neither FOXO1 nor Atrogin-1, the maineffect could be observed as deviations from PRE. For
both GAPDH and HADHA, we observed a downregula-
tion at the IMMO time point (−39% for GAPDH
(p = 0.001) and −24% for HADHA (p = 0.043)) and a sub-
sequent return to baseline expression, whereas for S26
we found a downregulation at the IMMO time point
that persisted throughout the REHAB (6 W) time point
(−26% at IMMO (p = 0.002) and −20% at REHAB
(p = 0.006) (Figure 3A).
Protein expression and phosphorylation
Contrary to the changes in muscle mass reported previ-
ously [28], we found no significant modulation of total
or phosphoprotein levels of Akt, GSK3β, 4EBP1, ubiqui-
tin or MURF1 in Study 2 (Figure 3B). Total and phos-
phorylated levels of mTOR and S6k were below the
detection threshold.
ba
Figure 3 Data for Study 2. A: mRNA expression measured by RT-qPCR. mRNA data are normalized to geometric means of Cyclophillin A, β2-
microglobulin and RPLP0 and are relative to individual PRE values. Target genes are presented in the left side panel, whereas putative
housekeeping genes are presented in the right side panel. Data are presented as back-transformed mean ± SEM. Light gray columns represent
IMMO and dark gray REHAB. B: Total protein and protein phosphorylation measured by Western blot, relative to individual PRE values. Data are
presented as back-transformed mean ± SEM. Total Akt is represented twice as it was measured along with each phospho-Akt. Light gray columns
represent IMMO and dark gray REHAB. * denotes a difference from PRE with 0.05> p≥ 0.01. ** denotes a difference from PRE with
0.01> p≥ 0.001. Underscored asterisks denote main (time) effects.
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For Study 1, we hypothesized that the 2 weeks
immobilization would decrease Akt and mTOR signaling
along with increased FOXO3, Atrogin-1 and MURF1
mRNA expression, reflecting the loss of muscle mass previ-
ously reported for this study [26]. We observed no changes
in Akt and mTOR signaling, and of FOXO3, Atrogin-1 and
MURF1 only FOXO3 was significantly downregulated after
immobilization, which is opposite of what we expected. Fur-
thermore, we hypothesized that the standard rehabilitation
would be insufficient to recover signaling and mRNA ex-
pression relative to post-immobilization. As hypothesized,
signaling and all mRNAs, except the downregulated
FOXO3, were unchanged with rehabilitation relative to the
IMMO time point.
For Study 2, we hypothesized (similar to study 1)
decreased Akt and mTOR signaling along with elevatedFOXO3, Atrogin-1 and MURF1 transcripts after
immobilization. Unexpectedly, Akt and mTOR signaling
and the measured mRNAs remained unchanged after
immobilization. Regarding the subsequent combined re-
sistance training and protein/carbohydrate supplementa-
tion based rehabilitation, we hypothesized a full recovery
of mass and strength, reflected by a reversal or
normalization to basal levels of signaling and mRNA ex-
pression. Indeed, this rehabilitation protocol restored
both mass and strength, whereas signaling and mRNA
expression remained unchanged after rehabilitation rela-
tive to post-immobilization.
Protein expression and phosphorylation
To our knowledge, we present the first results on Akt,
4E-BP1 and GSK3β phosphorylation following rehabilita-
tion after immobilization, and, unexpectedly, we show
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and Study 2, the total and phosphorylation levels of the
measured proteins remained unchanged after 2 weeks
immobilization. This is similar to a previous human
10 days immobilization study reporting unchanged total
and phosphorylated levels of Akt, S6k and 4E-BP1 [6], al-
though a decrease in Akt S473 phosphorylation after
20 days immobilization has been observed as well [34].
Of note, these studies [6,34] were performed on vastus
lateralis muscle, whereas our data is generated from
gastrocnemius muscle, which may affect the response.
Moreover, the high variation in the data may explain, at
least partly, the absence of significant differences with
time or treatment (Figures 2B and 3B). Due to this vari-
ation we cannot exclude the possibility that some minor
modulation occurs, but it is unlikely that the observed
variation masks large changes in phosphorylation status.
mRNA expression
Unexpectedly, we observed a significant decrease in FOXO3
and FOXO4 mRNA expression with immobilization as well
as rehabilitation in Study 1 (Figure 2A). This could be inter-
preted as an anti-catabolic response, but given that the sub-
jects were atrophic at the IMMO time point [26] and
anabolic at the REHAB time point, this represent a discrep-
ancy between the suggested gene function and the physio-
logical condition. We cannot rule out the possibility that
this response is secondary to other regulation events and
thus not part of a primary response. It is still a matter of de-
bate what the individual biological contributions of each
FOXO gene are and under what circumstances they are
activated, but murine in vitro and in vivo studies indicate
that the FOXO genes should be considered negative regula-
tors of muscle mass [20,35-37].
FOXO transcript behavior in vivo is poorly character-
ized with immobilization and our data represent novel
findings on the effects of immobilization and rehabilita-
tion on FOXO transcript regulation in human muscle.
Regarding the sparse literature that does exist, FOXO3
reporter activity has been shown to be upregulated with
immobilization in an animal model [38], whereas in a
human model, 3 and 20 days of unloading produced no
changes in FOXO1 or FOXO3 mRNA and protein ex-
pression levels [34,39].
As for the “atrogenes” Atrogin-1 and MURF1 [18,23],
in Study 2, we observed a tendency (p= 0.10) towards an
increase from PRE in Atrogin-1 expression (Figure 3A)
after immobilization. Both Atrogin-1 and MURF1 have
previously been shown to be upregulated in a 14-day
human immobilization study [7], although in that study,
the upregulation of MURF1 did not reach statistical sig-
nificance. Other time course studies show that Atrogin-1
and/or MURF1 expression increases in the initial phase
of immobilization and gradually declines, sometimeseven to levels below baseline [6,40]. Also, in the study by
Jones et al. [7], Atrogin-1 and MURF1 seem to return to
pre-levels with rehabilitation like in the present study,
but with an apparent “undershoot”, a finding we cannot
replicate due to our less detailed time course.
Normalization of mRNA expression
In the initial PCR assay we measured GAPDH and RPLP0
expression for normalization purposes, but as their expres-
sion changed in relation to each other, we proceeded to
measure more putative housekeeping genes (26S, β2-
microglobulin, Cyclophillin A and HADHA) in another
assay. Actually, we have previously shown that our most
frequently used normalization genes RPLP0 and GAPDH
change in rats with hindlimb unloading, relative to muscle
weight as well as relative to total RNA [41]. Accordingly,
we used the method suggested by Vandesompele et al. [32]
to determine which genes were the most stably expressed
and used those for normalization. This analysis indicated
GAPDH, HADHA and S26 to be the most variable of the
measured housekeeping genes. Indeed, in both of our
immobilization experiments, all of these genes displayed
decreases in expression with immobilization, with GAPDH
actually returning to baseline levels after rehabilitation
(Figures 2A and 3A), thereby making these genes highly
unsuitable for normalization purposes in immobilization
studies. This is particularly relevant for GAPDH, being
one of the most common normalization genes used and
due to it responding drastically to immobilization, thereby
not being fit for normalization purposes. This may have
implications for interpretation of existing immobilization
studies using GAPDH as an internal reference in RT-qPCR
analyses without further validation of housekeeping gene
expression stability [42-44], and should most certainly be
kept in mind in future immobilization studies measuring
mRNA expression.
Limitations
The discontinuous nature of these studies represents a
major limitation. The missing time points and discrepant
time courses do not allow for interstudy comparison,
which would otherwise have been informative. Moreover,
using the contralateral limb as a control in immobilization
studies is controversial as the contralateral limb may ex-
perience a compensatory training effect due to increased
stress [45]. This is especially true when combined with
protein/carbohydrate supplementation as this is thought
to contribute to hypertrophy only in conjunction with ex-
ercise or increased workload [46]. Therefore, the contralat-
eral leg cannot be considered a true, passive control within
this study.
The variation in our Western blots was higher than
expected; part of this can likely be ascribed to keeping
our stock samples in a native buffer. Since then, we have
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sample homogenization yields more consistent results.
In Study 1, no exercise logs were maintained, and this
could mask low compliance, which in turn could cause
impaired rehabilitation efficiency. Moreover, it must be
noted that the ingestion of supplements were only super-
vised on post-workout occasions, allowing for compli-
ance issues.
Conclusions
In Study 2, we observed full strength recovery after
2 weeks of rehabilitation. In both studies, no changes in
protein expression or phosphorylation for any measured
protein were observed. In Study 1, FOXO3 and FOXO4
mRNA expression decreased after IMMO and REHAB
compared to PRE, whereas other mRNAs remained un-
changed. Interestingly, we found significant changes in
expression of the putative housekeeping genes GAPDH,
HADHA and S26 with immobilization in both studies.
Accordingly, in either study, changes in muscle mass
after immobilization and subsequent rehabilitation were
not reflected in total protein or phosphorylation status of
Akt and mTOR pathway components. The changes in
the so-called housekeeping genes GAPDH, HADHA and
S26 with immobilization in both studies question the
usefulness of these genes for normalization purposes in
muscle immobilization studies, and a more thorough
characterization of changes in housekeeping genes is of
relevance to future immobilization studies.
In perspective, this calls for further research, preferably
a full randomized controlled trial, comparing the contri-
butions of protein/carbohydrate supplementation and re-
sistance training, individually as well as in combination,
on immobilization-induced atrophy and rehabilitation-
induced hypertrophy and related molecular regulation.
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